ClouDr Group Ltd

09955

Company Profile

  • Business description

    ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. The company’s in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies, and out-of-hospital solution connects doctors and patients, and provides high-quality and trustworthy medical services through AI vertical model ClouD GPT. The company generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

  • Contact

    No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street
    Rooms 501, 5th Floor, Building 12
    Yuhang District
    Zhejiang Province
    Hangzhou
    CHN

    https://www.cloudr.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    31 December 2025

    Employees

    1,218

Stocks News & Analysis

stocks

Potentially catastrophic ruling for ASX company

We raise our risk and uncertainty rating to reflect the impact of the ruling.
stocks

4 charts on Nvidia’s record $4 trillion market cap

Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.
stocks

Could merger breathe new life into struggling ASX asset manager?

Platinum’s board voted unanimously in favour of a merger we expect would be value accretive.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,815.305.00-0.06%
CAC 407,808.1721.12-0.27%
DAX 4024,160.6494.67-0.39%
Dow JONES (US)44,392.4120.900.05%
FTSE 1008,998.0656.940.64%
HKSE24,203.3263.750.26%
NASDAQ20,638.0252.490.26%
Nikkei 22539,459.62110.06-0.28%
NZX 50 Index12,678.697.99-0.06%
S&P 5006,264.364.610.07%
S&P/ASX 2008,570.409.70-0.11%
SSE Composite Index3,519.659.470.27%

Market Movers